✦ LIBER ✦
Interim analysis of phase II efficacy and safety data for eculizumab in patients with atypical hemolytic uremic syndrome (aHUS) receiving chronic plasma exchange/infusion
✍ Scribed by T.H.J. Goodship; P. Muus; C. Legendre; K. Douglas; M. Hourmant; Y. Delmas; M. Herthelius; A. Trivelli; C. Loirat; C. Bedrosian; C. Licht
- Book ID
- 113805546
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 65 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0161-5890
No coin nor oath required. For personal study only.